MIA Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-MIA antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | MIA |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse, rat |
| Isotype | n/a |
| Format | immunogen affinity purified |
| Size | 0.03 mL, 0.1 mL, 0.2 mL |
| Concentration | 1 mg/ml |
| Applications | Immunohistochemistry (IHC) Paraffin, ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: MIA Polyclonal Antibody detects endogenous levels of MIA protein. Tumorigenesis is a process that is mediated by a network of membrane, cytosolic and nuclear associated factors, which regulate proliferation and cell-matrix interaction through signaling cascades. The phenotype of malignant melanomas in vivo depends on the global expression of stimulatory or inhibitory factors generated in both the tumors cells and their environment. One example, Melanoma inhibitory activity (cartilage-derived retinoic acid-sensitive protein (CD-RAP), MIA) is a Src homology 3 (SH3)-like domain containing protein that is secreted from chondrocytes and malignant melanoma cells. MIA is translated as a 131-amino acid pro-form and processed into a mat |
| Immunogen | Immunogen: Synthesized peptide derived from the C-terminal region of human MIA at AA range: 60-140 |
| Other Names | [Rabbit MIA; MIA; Melanoma-derived growth regulatory protein; Melanoma inhibitory activity protein] |
| Gene, Accession # | [MIA], Gene ID: 8190, NCBI: NP_001189482.1, UniProt: Q16674 |
| Catalog # | MBS9707277 |
| Price | $130, $220, $325 |
| Order / More Info | MIA Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies